• 05 December, 2022
Geopolitics & National Security.
MENU

trials

India’s Advanced Towed Artillery Gun System (ATAGS)

The National drive to ‘Make in India’ in order to achieve self-reliance in industrial capabilities, particularly in Defence manufacturing, has spawned several projects, ranging from the TEJAS aircraft to various…

By Brig Arvind Dhananjayan (Retd)

Army variant of Medium Range Surface-to-Air Missile system completes development trials

Medium Range Surface-to-Air Missile (MRSAM) Army weapon system has once again proved its effectiveness as two missiles, during the flight tests, achieved direct hits against high speed aerial targets at…

Russia’s Putin took part in trials of nasal form of COVID vaccine

MOSCOW (Reuters) - Russian President Vladimir Putin said on Wednesday he had participated in trials of a nasal form of a vaccine against COVID-19. Putin was revaccinated against the coronavirus…

India’s Dhanush Howitzer: Has The Phoenix Risen?

In an effort towards modernising its Artillery profile, the Indian Army (IA) embarked upon the Field Artillery Rationalisation Plan (FARP) post the 1999 Kargil War, with a vision towards streamlining…

By Brig Arvind Dhananjayan (Retd)

British study to test mixed COVID-19 vaccine dose schedules in children

By Alistair Smout LONDON (Reuters) - A British study will look into the immune responses of children to mixed schedules of different COVID-19 vaccines as officials try to determine the…

COVAXIN trial results on children likely by September: AIIMS chief Dr Randeep Guleria

By Shalini Bhardwaj New Delhi [India], July 24 (ANI): Trials for Bharat Biotech's Covid-19 vaccine Covaxin on children are underway and results are expected to be released by September, All…

Inhaled COVID-19 vaccine prevents disease, virus transmission in animals: Study

Washington [US], July 9 (ANI): In a new study assessing the potential of a single-dose, intranasal COVID-19 vaccine, a team from the University of Iowa and the University of Georgia…

Bharat Biotech’s Covaxin shows 77.8 pc efficacy in Phase III trials, say sources

By Shalini Bhardwaj New Delhi [India], June 22 (ANI): Bharat Biotech's Covaxin has shown 77.8 per cent efficacy after the Subject Expert Committee (SEC) under the drug regulator reviewed its…

Novavax results are promising, hope company starts trial on children soon: Centre

New Delhi [India], June 15 (ANI): The Centre on Tuesday said clinical trials of the Novavax COVID-19 vaccine in India are in an advanced stage of completion and hoped the…

Novavax’s vaccine, also produced by SII, found 90 pc effective against COVID-19 variants

By Sahil Pandey New Delhi [India], June 14 (ANI): US Biotechnology company Novavax on Monday announced that its Covid-19 vaccine provides 100 per cent protection against moderate and severe symptoms…

DCGI approves anti-COVID drug developed by DRDO for emergency use

In a major boost to India's fight against Covid 19 and treatment of patients as well as Atmanirbhar Bharat, the Drug Controller has approved an anti COVID drug developed by…

LCA Tejas succesfully test fires 5th generation Python-5 Close Ccombat Missile

In a significant move to advance the weapons portfolio of the indigenously developed fighter, India's state-owned Defence Research and Development Organisation (DRDO) has successfully conducted the flight trials of the…